Screener

Eligibility screening

Lisocabtagene Maraleucel (Liso-cel) for Transplant-Ineligible PCNSL

Sponsored by Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyStudy detailsClinicalTrials.gov

30 US sites in CA, CO, FL, IL +9

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.